ArriVent BioPharma
AVBP
#5762
Rank
C$1.26 B
Marketcap
$37.47
Share price
-0.42%
Change (1 day)
N/A
Change (1 year)

Revenue for ArriVent BioPharma (AVBP)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ArriVent BioPharma from 2023 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A
2023 N/A